Genzyme resumed production of Cerezyme, its drug for Gaucher's disease, after contamination problems forced the company to stop manufacturing the drug for a month. Report
Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product
Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.
